Welcome to CDC stacks | The National Center for Immunization and Respiratory Diseases 2008 annual report - 5664 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The National Center for Immunization and Respiratory Diseases 2008 annual report
  • Published Date:
    2008
Filetype[PDF-2.05 MB]


Details:
  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
  • Description:
    Mission -- Priorities 2008-2010 -- Healthy people in every stage of life -- Healthy people in healthy places -- Healthy people in a healthy world -- People prepared for emerging health threats -- Appendix

    "The National Center for Immunization and Respiratory Diseases is completing its second year with a renewed commitment to make a difference. Thanks to the hard work of CDC staff and partners, our collective efforts are paying off. Immunization Action: To deliver on the promise of the recently recommended vaccines for 11 and 12 year olds -- Tdap, meningococcal conjugate, and HPV vaccine (for girls) -- we launched a preteen immunization campaign, funded adolescent coordinators for state programs, and spotlighted new communication materials (www.cdc.gov/vaccines). We reported substantial drops in both pneumonia hospitalizations and direct medical care costs due to pneumococcal conjugate vaccine use. A record number of influenza vaccine doses were distributed for the 2007/8 season. We addressed our share of challenges, too, including selected vaccine shortages and transitioning more areas to centralized vaccine distribution. Respiratory Disease Response: Together with state, local, and international public health counterparts, we responded to a new strain of Adenovirus type 14, swine influenza human cases associated with agricultural events, and outbreaks of Legionnaires disease, Mycoplasma pneumoniae, pertussis, and pneumococcus. H5N1 avian influenza sustained its high virulence in human cases. In partnership with the Council on State and Territorial Epidemiologists, we strengthened domestic influenza surveillance with strategies that will improve both seasonal and pandemic influenza efforts. Looking Back: We tallied the remarkable impact on illness and death that vaccines have had, compared with historical data -- more than 99% reductions are evident for several of the vaccine-preventable diseases assessed (Roush JAMA 2007). Continued exploration of the reconstructed 1918 pandemic influenza virus revealed more clues to the molecular basis of its transmissibility and virulence. Looking Forward: Strengthening preparedness was front and center. NCIRD provided pandemic and avian influenza training to international staff, rapid response teams, laboratory personnel, Epidemic Intelligence Service officers, and others. CDC-wide exercises and tabletops on pandemic influenza expanded the numbers of CDC staff that are familiar with response plans. Strategic planning around CDC's health protection goals and the agency's immunization and respiratory disease efforts accelerated." - director's letter

  • Document Type:
  • Place as Subject:
No Related Documents.
You May Also Like: